KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Debt Ratio (2017 - 2023)

Bionano Genomics' Debt Ratio history spans 5 years, with the latest figure at 0.05 for Q3 2023.

  • For Q3 2023, Debt Ratio rose 91.28% year-over-year to 0.05; the TTM value through Sep 2023 reached 0.05, up 91.28%, while the annual FY2022 figure was 0.03, N/A changed from the prior year.
  • Debt Ratio for Q3 2023 was 0.05 at Bionano Genomics, up from 0.04 in the prior quarter.
  • Across five years, Debt Ratio topped out at 1.03 in Q3 2019 and bottomed at 0.03 in Q2 2022.
  • The 5-year median for Debt Ratio is 0.27 (2020), against an average of 0.36.
  • The largest annual shift saw Debt Ratio crashed 95.65% in 2021 before it skyrocketed 91.28% in 2023.
  • A 5-year view of Debt Ratio shows it stood at 0.66 in 2019, then crashed by 59.38% to 0.27 in 2020, then plummeted by 85.7% to 0.04 in 2021, then dropped by 21.01% to 0.03 in 2022, then soared by 80.18% to 0.05 in 2023.
  • Per Business Quant, the three most recent readings for BNGO's Debt Ratio are 0.05 (Q3 2023), 0.04 (Q2 2023), and 0.03 (Q1 2023).